On April 9, 2014, Liu, Changdou published a patent.Safety of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate The title of the patent was Compound levofloxacin hydrochloride soluble powder for treating respiratory system disease of poultry. And the patent contained the following:
The title compound levofloxacin hydrochloride soluble powder is prepared by mixing the following components: levofloxacin hydrochloride 2-10%, azithromycin 2-10%, Bufonis Venenum 2-6%, licorice extract 10-30%, Kameiding 3-9%, trimethoprim lactate 1-5%, and the balance of pharmaceutically applicable auxiliary materials (sucrose, anhydrous glucose, oral glucose, and/or starch). The invention adopts the latest market medicine, traditional Chinese medicinal extract, novel antiasthmatic medicine and medicine synergist compound into compound preparation, and has antiinflammatory, antibacterial, antiviral, heart tonifying, cough relieving, anti-allergic, poultry disease resistance and immunity increasing, damaged mucosa repairing, secondary infection controlling, and poultry respiratory system disease treating effects. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Safety of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
The Article related to levofloxacin hydrochloride soluble powder respiratory system disease poultry, Pharmaceuticals: Formulation and Compounding and other aspects.Safety of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia